By Michael Gwarisa, recently in Masvingo For the past 12 months, Wellington*, a 41-year-old Masvingo man who has sex with men (MSM) and a male sex worker, has relied on oral Pre-Exposure Prophylaxis (PrEP) to reduce his risk of HIV infection. He has also used condoms and occasionally Post-Exposure Prophylaxis (PEP). At the start of 2025, Wellington hoped he would be initiated on the injectable form of PrEP, Cabotegravir Long-Acting (CAB-LA), to further protect himself. But like many other HIV prevention services, the injectable program had been suspended following the…
Read MoreSuspended HIV Services Resume in Masvingo as CAB-LA, Vaginal Ring Return for Key Populations
